Trending Posts

Recent in news
How Eli Lilly-Backed Persist AI Secured $12M to…

Key highlights Persist AI, a healthcare deep tech startup based in Sacramento, CA, has successfully raised $12 million…

ByByAnuja Singh May 27, 2025
How Is WorkDoneAI Transforming Healthcare Documentation Compliance with…

Key Highlights of WorkDone’s $1.8M Seed Funding: San Francisco, CA – WorkDone, a Y Combinator-backed healthcare AI startup,…

ByByAnuja Singh May 26, 2025
How Is TrialMatchAI from Bordeaux Bioinformatics Center Revolutionizing…

Key Highlights: The Bordeaux Bioinformatics Center, in collaboration with the EOSC4Cancer initiative, has unveiled TrialMatchAI, an advanced AI-driven…

ByByAnuja Singh May 26, 2025
How Can AI Transform Cancer Treatment? KOLs Insights…

Baltimore, MD — With the rapid advancement of artificial intelligence (AI), predictive medicine is becoming a pivotal part…

ByByAnuja Singh May 25, 2025
How Heidi Health’s $16.6M Raise Is Empowering Clinicians…

Heidi Health Secures $16.6M to Revolutionize Clinical Workflows with AI-Powered Scribe Melbourne, Australia – March 3, 2025 –…

ByByAnuja Singh May 25, 2025
Can Hinge Health’s $100 Million IPO Redefine AI-Powered…

San Francisco, CA – 25 May 2025 Key Highlights > IPO Launch: Hinge Health targets $100 million raise…

ByByAnuja Singh May 25, 2025
AI Meets Genomics: Predictive Oncology’s PEDAL™ Platform Advances…

Breakthrough aligns with Regeneron’s genomics strategy, signaling acceleration in precision oncology development PITTSBURGH, May 22, 2025 – Predictive…

ByByAnuja Singh May 24, 2025
How Qubit Pharmaceuticals’ Quantum AI Model FeNNix-Bio1 is…

May 23, 2025 Advancing Molecular Simulation for Faster Drug Development Qubit Pharmaceuticals, in collaboration with Sorbonne University, has…

ByByAnuja Singh May 23, 2025
Can AI-Powered Screening Revolutionize Cancer Detection in India?…

May 23, 2025 A Nationwide Step Toward Preventive Cancer Care Metropolis Healthcare Limited has introduced TruHealth Cancer Screen…

ByByAnuja Singh May 23, 2025

Latest Stories

Don’t miss our hot and upcoming stories
Could Roche and Alnylam’s Phase III Trial of Zilebesiran Redefine Hypertension Care for 1.2 Billion Patients Worldwide?

Key Highlights Phase II Data Paves the WayThe KARDIA clinical program—spanning three Phase II trials—has…

ByByAnuja Singh Aug 31, 2025
Can AstraZeneca’s $50B US Investment and Eli Lilly’s $27B Manufacturing Expansion Reshape the Future of American Biopharma?

Key Highlights Virginia Bets Big on Biopharma GrowthVirginia lawmakers have approved significant development packages to…

ByByAnuja Singh Aug 31, 2025
Can Cambridge and A*STAR’s New AI Digital Twin Platform Transform $50Bn Pharma Manufacturing Efficiency Landscape?

Key Takeaways AI-Driven Digital Twin for PharmaThe newly launched platform integrates AI with real-time plant…

ByByAnuja Singh Aug 31, 2025
Can Roche’s $700M Genentech Facility Drive Its $50B US Investment Strategy and Transform Obesity Drug Manufacturing?

Key Highlights Strategic Expansion into US ManufacturingGenentech, Roche’s US subsidiary, has broken ground on a…

ByByAnuja Singh Aug 30, 2025
Scroll to Top